Drawing for CELLHESION

USPTO serial 79237778

CELLHESION

Reviewed by CopyMark Law Group

Reg. 5772148Status 708Registered
Filing date
Status date
Registration date
Jun 11, 2019
Examiner
MORENO, PAUL A
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with CELLHESION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ee Ming T. Bahk

Ee Ming T. Bahk Oliff PLCP.O. Box 320850Alexandria, VA 22320-4850United States

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in industry and science, namely, chemical media additives; chemical preparations for use in industry, namely, chemical media additives; chemical preparations for scientific purposes, namely, chemical media additives; chemical media additives, other than for medical or veterinary purposes; chemical media additives in kit form, other than for medical or veterinary purposes; chemical media additives for scientific or research purposes, other than for medical or veterinary purposes; [ chemical media additives in kit form for scientific or research purposes, other than for medical or veterinary purposes; ] chemical media additives for cell culture, other than for medical or veterinary purposes; chemical media additives for tissue culture, other than for medical or veterinary purposes; chemical media additives for culture of microorganisms, other than for medical or veterinary purposes; media for cell culture for scientific or research purposes, other than for medical or veterinary purposes; media for tissue culture for scientific or research purposes, other than for medical or veterinary purposes; [ media for culture of microorganisms for scientific or research purposes, other than for medical or veterinary purposes; ] media for three-dimensional cell culture for scientific or research purposes, other than for medical or veterinary purposes; media for three-dimensional tissue culture for scientific or research purposes, other than for medical or veterinary purposes; [ media for three- dimensional culture of microorganisms for scientific or research purposes, other than for medical or veterinary purposes; ] media for cell culturing for laboratory use; dispersing agents; chemical media additives for use in separation of cells, other than for medical or veterinary purposes; [ media for cell culture in kit form for scientific or research purposes, other than for medical or veterinary purposes; media for tissue culture in kit form for scientific or research purposes, other than for medical or veterinary purposes; media for culture of microorganisms in kit form for scientific or research purposes, other than for medical or veterinary purposes; all of the above not including reagents and diagnostic materials ]ACTIVE—
005[ Pharmaceutical preparations for use in regenerative medicine, oncology and hematology; pharmaceutical preparations for the treatment of viral and infectious diseases, autoimmune diseases, kidney diseases, hepatic diseases, neurological diseases and bone diseases; chemical media additives for medical or veterinary purposes; chemical media additives in kit form for medical or veterinary purposes; chemical media additives for cell culture, for medical or veterinary purposes; chemical media additives for tissue culture, for medical or veterinary purposes; chemical media additives for culture of microorganisms, for medical or veterinary purposes; culture media for use in regenerative medicine, oncology, hepatology and hematology; culture media for augmentation of bone and other tissues for medical purpose using iPS/ES cells and other stem cells; culture media for use to produce biomedicine, in particular antibody medicines and vaccine medicines; culture media of microorganisms for medical use; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; all of the above not including reagents and diagnostic materials ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 27, 2026INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Aug 27, 2025NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Aug 27, 2025C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
Aug 25, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 28, 2025ES75TEAS SECTION 71 & 15 RECEIVED—
Dec 12, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 11, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 25, 2019FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 5, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 5, 2019FIMPFINAL DISPOSITION PROCESSED—
Sep 11, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 11, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 26, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 26, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 23, 2019GPNXNOTIFICATION PROCESSED BY IB—
Mar 6, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 6, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 6, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 19, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 19, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 19, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 11, 2019ALIEASSIGNED TO LIE—
Feb 7, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 13, 2018ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Nov 30, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 30, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 30, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 26, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 26, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 21, 2018RFNTREFUSAL PROCESSED BY IB—
Sep 5, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 5, 2018RFRRREFUSAL PROCESSED BY MPU—
Aug 21, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 20, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 10, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 6, 2018DOCKASSIGNED TO EXAMINER—
Aug 6, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 3, 2018LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Aug 2, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance